Medication for mental health: Oral health impacts

shutterstock_146973512

This review of the side effects of medications prescribed for the management of mental health highlights their potential impact on oral health. The commonest problems being xerostomia.

[read the full story...]

Should people with schizophrenia be offered depot antipsychotics as first line treatment?

injection-1294131_1280

Murtada Alsaif reports on a new nationwide Swedish cohort study that explores the real-world effectiveness of oral and depot antipsychotics for people with schizophrenia.

[read the full story...]

Psychotropic medication: finding ways forward for adults with intellectual disabilities #RSMpsychotropics

32636946385_3d32a2f81b_k

Rory Sheehan and Angela Hassiotis discuss how to optimise psychotropic medication for people with intellectual disabilities; the theme of their #RSMpsychotropics conference taking place in London today.

[read the full story...]

Antidepressants for bipolar depression: weighing up the benefits and harms

7347845622_508b764a51_k

Murtada Alsaif considers a recent systematic review on the safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression.

[read the full story...]

Antipsychotics for delirium in palliative care: new RCT suggests non-drug alternatives are needed

shutterstock_73696783

Samei Huda highlights a recent RCT of antipsychotics (risperidone and haloperidol) versus placebo for symptoms of delirium in palliative care, which suggests we need non-drug alternatives for this group of patients.

[read the full story...]

Risperidone versus placebo for people with schizophrenia

14397363653_f60cbb91b2_k

Joanne Wallace summarises the recent Cochrane systematic review on risperidone versus placebo for schizophrenia, which concludes that the best available evidence does not show that the benefits of risperidone outweigh the harms.

[read the full story...]

Antipsychotic efficacy measured by real-world observational study

telescope-1082091_640

Tracey Roberts examines whether a retrospective observational study accurately investigates the effectiveness of second and first generation antipsychotics.

[read the full story...]

Depot antipsychotics: If you pay me, you can keep injecting me

15957442702_af350ecae9_k

John Baker looks at the 2-year follow-up results of a cluster RCT on the effectiveness of financial incentives to improve adherence to maintenance treatment with depot antipsychotics.

[read the full story...]

Bipolar disorder in older men linked to increased risk of dementia

15596232627_88e725fe30_k

Elena Marcus presents a recent study that shows how older Australian men with bipolar disorder have an increased risk of dementia and early death.

[read the full story...]

The side-effects of antipsychotics: let’s systematically assess, discuss and act! #NPNR2016

w6txmc29-1358999171

A live blog published at the 22nd International Network for Psychiatric Nursing Research conference in Nottingham.

Written by John Baker, Lucy Brazener, Wendy Cross, Vanessa Garrity, Andrew Grundy, Cher Hallett, Ben Hannigan, Elaine Hanzak and Alan Simpson.

[read the full story...]